BOCA RATON, Fla., March 27, 2018 /PRNewswire/ — New research from MDVIP and Cleveland HeartLab finds that patients with diabetes, pre-diabetes or no evidence of diabetes whose physicians ordered myeloperoxidase (MPO) inflammation testing achieved sharp reductions in MPO levels over five years. The investigators theorize the levels declined over time as a result […]



